KEGG   DRUG: ElapegademaseHelp
Entry
D11017                      Drug                                   

Name
Elapegademase (INN);
Elapegademase (genetical recombination) (JAN);
Elapegademase-lvlr;
Revcovi (TN)
Product
Sequence
AQTPAFNKPK VELHVHLDGA IKPETILYYG RKRGIALPAD TPEELQNIIG MDKPLSLPEF
LAKFDYYMPA IAGSREAVKR IAYEFVEMKA KDGVVYVEVR YSPHLLANSK VEPIPWNQAE
GDLTPDEVVS LVNQGLQEGE RDFGVKVRSI LCCMRHQPSW SSEVVELCKK YREQTVVAID
LAGDETIEGS SLFPGHVKAY AEAVKSGVHR TVHAGEVGSA NVVKEAVDTL KTERLGHGYH
TLEDTTLYNR LRQENMHFEV CPWSSYLTGA WKPDTEHPVV RFKNDQVNYS LNTDDPLIFK
STLDTDYQMT KNEMGFTEEE FKRLNINAAK SSFLPEDEKK ELLDLLYKAY GMPSPA
  Type
Peptide
Remark
Therapeutic category: 3959
Product: D11017<JP/US>
Efficacy
Enzyme replacement (adenosine deaminase)
  Disease
Adenosine deaminase severe combined immune deficiency [DS:H02309]
Comment
Enzyme replacement therapy product
Interaction
Drug interaction
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   395  Enzyme preparations
    3959  Others
     D11017  Elapegademase (INN); Elapegademase (genetical recombination) (JAN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11017
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11017
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11017
BRITE hierarchy
Other DBs
CAS: 1709806-75-6
PubChem: 348350489
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system